SADC Ministers approved Medicines Regulatory Guidelines:

Member States were assigned to conclude Guideline development by November 2004

The following countries were indicated as responsible for the finalisation of these
guidelines:

Guidelines for Drug Donations SADC/HM/2/2006/6.10a Completed --Lesot

Guidelines for Pharmacovigilance SADC/HM/2/2006/6.10b
Guidelines on import and export procedures SADC/HM/2/2006/6.10c Completed- Zambi
for pharmaceutical products
Guidelines for Pharmaceutical Wholesale SADC/HM/2/2006/6.10d Completed- Zambi
Dealing
Advertising – South Africa SADC/HM/2/2006/6.10e status unclear
Draft SADC Advertising Guidelines
Guidelines for Retail Pharmacy SADC/HM/2/2006/6.7f Completed
Adverse drug reactions – Swaziland; (submit to next Min
Post-Marketing surveillance- Zimbabwe; (submit to next Min
Forms – Lesotho (submit to next Min
Nutritional supplements – Tanzania; (submit to next Min
Complementary medicines – Botswana and (submit to next Min
Zimbabwe
Clinical Trials – South Africa No target date for re
Licensing of Manufactures – Mozambique No target date for re
Recalls – South Africa No target date for re
Terms and definitions – Malawi and Tanzania No target date for re
Validation – Zimbabwe No target date for re